Bruno Giros

Author PubWeight™ 75.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003 15.31
2 A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J Neurosci 2002 2.71
3 Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice. Am J Hum Genet 2008 1.65
4 The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone. Nat Neurosci 2008 1.57
5 Zebrafish atlastin controls motility and spinal motor axon architecture via inhibition of the BMP pathway. Nat Neurosci 2010 1.52
6 Paradoxical increase in survival of newborn neurons in the dentate gyrus of mice with constitutive depletion of serotonin. Eur J Neurosci 2013 1.49
7 Loss of X-linked mental retardation gene oligophrenin1 in mice impairs spatial memory and leads to ventricular enlargement and dendritic spine immaturity. J Neurosci 2007 1.48
8 L-DOPA impairs proteasome activity in parkinsonism through D1 dopamine receptor. J Neurosci 2012 1.43
9 Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology 2006 1.30
10 VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety. J Neurosci 2010 1.29
11 Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background. Eur J Neurosci 2004 1.11
12 Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation. J Neurosci 2004 1.06
13 Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice. J Neurochem 2008 1.05
14 Morphometric characterization of microglial phenotypes in human cerebral cortex. J Neuroinflammation 2014 1.04
15 Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: neural and behavioral consequences. Neuropsychopharmacology 2011 1.03
16 Developmentally regulated expression of VGLUT3 during early post-natal life. Neuropharmacology 2005 1.01
17 Microtubule-associated STOP protein deletion triggers restricted changes in dopaminergic neurotransmission. J Neurochem 2008 1.00
18 Endogenous morphine-like compound immunoreactivity increases in parkinsonism. Brain 2011 1.00
19 Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications. Biol Psychiatry 2005 1.00
20 Parallel loss of hippocampal LTD and cognitive flexibility in a genetic model of hyperdopaminergia. Neuropsychopharmacology 2007 0.98
21 Selective cortical VGLUT1 increase as a marker for antidepressant activity. Neuropharmacology 2005 0.98
22 The deletion of STOP/MAP6 protein in mice triggers highly altered mood and impaired cognitive performances. J Neurochem 2012 0.97
23 Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease. Neurobiol Aging 2006 0.97
24 Epilepsy in Dcx knockout mice associated with discrete lamination defects and enhanced excitability in the hippocampus. PLoS One 2008 0.96
25 The deletion of the microtubule-associated STOP protein affects the serotonergic mouse brain network. J Neurochem 2010 0.96
26 Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease. Neurobiol Aging 2007 0.96
27 Postnatal growth defects in mice with constitutive depletion of central serotonin. ACS Chem Neurosci 2012 0.95
28 Schizotypal dimensions: an intermediate phenotype associated with the COMT high activity allele. Am J Med Genet B Neuropsychiatr Genet 2007 0.91
29 The reinforcing effects of chronic D-amphetamine and morphine are impaired in a line of memory-deficient mice overexpressing calcineurin. Eur J Neurosci 2005 0.91
30 Functional alterations of nicotinic neurotransmission in dopamine transporter knock-out mice. Neuropharmacology 2007 0.91
31 Altered cocaine-induced behavioral sensitization in adult mice exposed to cocaine in utero. Brain Res Dev Brain Res 2003 0.90
32 Interaction between the vesicular glutamate transporter type 1 and endophilin A1, a protein essential for endocytosis. J Neurochem 2006 0.90
33 Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm. Int J Neuropsychopharmacol 2010 0.90
34 Nicotine improves cognitive deficits of dopamine transporter knockout mice without long-term tolerance. Neuropsychopharmacology 2007 0.89
35 Interactions between the cannabinoid and dopaminergic systems: evidence from animal studies. Prog Neuropsychopharmacol Biol Psychiatry 2012 0.88
36 [Genetics of autism: from genome scans to candidate genes]. Med Sci (Paris) 2003 0.87
37 Augmented constitutive CREB expression in the nucleus accumbens and striatum may contribute to the altered behavioral response to cocaine of adult mice exposed to cocaine in utero. Dev Neurosci 2005 0.86
38 Maternal deprivation specifically enhances vulnerability to opiate dependence. Behav Pharmacol 2006 0.86
39 Lysosomal amino acid transporter LYAAT-1 in the rat central nervous system: an in situ hybridization and immunohistochemical study. J Comp Neurol 2003 0.86
40 Association between the PPP3CC gene, coding for the calcineurin gamma catalytic subunit, and bipolar disorder. Behav Brain Funct 2008 0.85
41 Sustained increase of alpha7 nicotinic receptors and choline-induced improvement of learning deficit in STOP knock-out mice. Neuropharmacology 2007 0.84
42 Maternal deprivation increases vulnerability to morphine dependence and disturbs the enkephalinergic system in adulthood. J Neurosci 2005 0.84
43 Maternal deprivation induces depressive-like behaviours only in female rats. Behav Brain Res 2010 0.83
44 Doublecortin knockout mice show normal hippocampal-dependent memory despite CA3 lamination defects. PLoS One 2013 0.83
45 Brief early handling increases morphine dependence in adult rats. Behav Brain Res 2006 0.82
46 Maternal deprivation increases behavioural reactivity to stressful situations in adulthood: suppression by the CCK2 antagonist L365,260. Psychopharmacology (Berl) 2005 0.82
47 Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801. Neuropharmacology 2011 0.81
48 Chronic valproate normalizes behavior in mice overexpressing calcineurin. Eur J Pharmacol 2007 0.81
49 Constitutive hyperdopaminergia is functionally associated with reduced behavioral lateralization. Neuropsychopharmacology 2005 0.80
50 Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3. Naunyn Schmiedebergs Arch Pharmacol 2012 0.80
51 Rose Bengal analogs and vesicular glutamate transporters (VGLUTs). Bioorg Med Chem 2010 0.80
52 Maternal deprivation induces deficits in temporal memory and cognitive flexibility and exaggerates synaptic plasticity in the rat medial prefrontal cortex. Neurobiol Learn Mem 2012 0.80
53 Inhibitory and facilitory actions of isocyanine derivatives at human and rat organic cation transporters 1, 2 and 3: a comparison to human alpha 1- and alpha 2-adrenoceptor subtypes. Eur J Pharmacol 2010 0.79
54 Inhibition of dopamine transporter activity impairs synaptic depression in rat prefrontal cortex through over-stimulation of D1 receptors. Cereb Cortex 2012 0.79
55 Both chronic treatments by epothilone D and fluoxetine increase the short-term memory and differentially alter the mood status of STOP/MAP6 KO mice. J Neurochem 2012 0.79
56 Evidence of long-term expression of behavioral sensitization to both cocaine and ethanol in dopamine transporter knockout mice. Psychopharmacology (Berl) 2009 0.78
57 Vulnerability to opiate intake in maternally deprived rats: implication of MeCP2 and of histone acetylation. Addict Biol 2013 0.78
58 Maternal deprivation and handling modify the effect of the dopamine D3 receptor agonist, BP 897 on morphine-conditioned place preference in rats. Psychopharmacology (Berl) 2007 0.78
59 Possible involvement of endocannabinoids in the increase of morphine consumption in maternally deprived rat. Neuropharmacology 2012 0.77
60 Genetic markers in psychiatric genetics. Methods Mol Med 2003 0.77
61 Adolescent exposure to chronic delta-9-tetrahydrocannabinol blocks opiate dependence in maternally deprived rats. Neuropsychopharmacology 2009 0.77
62 The dopamine D1 receptor agonist SKF 38393 improves temporal order memory performance in maternally deprived rats. Neurobiol Learn Mem 2013 0.76
63 Antipsychotics increase vesicular glutamate transporter 2 (VGLUT2) expression in thalamolimbic pathways. Neuropharmacology 2007 0.75
64 Early stress leads to effects on estrous cycle and differential responses to stress. Physiol Behav 2010 0.75